Back to all news
Hybrid AI-Human Mammography Reading Cuts Workload Without Compromising Cancer Detection
A hybrid AI and radiologist reading strategy for screening mammography reduced radiologist workload by 38% without affecting recall or cancer detection rates.
Key Details
- 1A Radboud University Medical Center team trialed a hybrid AI-human method for reading screening mammograms.
- 2Radiologist workload dropped by 38% while recall (23.6%) and cancer detection rates (6.6%) matched standard double reading.
- 3Study included 41,469 mammograms from 15,522 women in the Dutch National Breast Cancer Screening Program, spanning from 2003–2018.
- 4The AI (ScreenPoint Medical) handled confident predictions; radiologists reviewed cases with uncertain AI output.
- 5Uncertainty estimation (entropy of probability of malignancy) was key to triaging cases.
- 6Only one cancer case was missed by AI but caught by radiologist using this hybrid approach (ductal carcinoma in situ).
Why It Matters
This evidence supports the clinical adoption of hybrid AI models to maintain diagnostic accuracy while meaningfully reducing radiologists' workload in breast cancer screening. Incorporating AI uncertainty metrics appears crucial in such workflows, potentially improving efficiency and trust in AI-assisted interpretation.
Source
AuntMinnie
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
New Rubric Enhances Safety of AI-Generated Radiology Summaries
Researchers developed a five-factor rubric to assess the safety and quality of AI-generated, patient-friendly radiology report summaries.
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.